Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Perspectum Diagnostics – a spinout from the Radcliffe Department of Medicine – has reinvested money in the University of Oxford, to fund a three year multicentre European health economic study into methods of diagnosing fatty liver disease. This first of three payments totaling €759,999, is part of a €3.4m project, won by Perspectum in the H2020 grant competition.

© Perspectum Diagnostics
Liver scan. Image credit, Perspectum Diagnostics

Perspectum Diagnostics has developed an MRI scanning technique to detect and monitor non-alcoholic fatty liver disease (NAFLD) – a rising concern due to its links with obesity and diabetes. LiverMultiScan offers a safe and non-invasive method to aid diagnosis of liver disorders. Patients are already benefitting from the technology, which was introduced in Europe and the U.S. as a research device in 2014. It has now been made available in leading medical institutions in 50 hospitals, globally.

Read more (Radcliffe Department of Medicine website)

Similar stories

Potential for radiotherapy and VTP multimodality therapy for prostate cancer

A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Oxford University and partners win government funding to evaluate Paige Prostate Cancer Detection System

A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University as part of a successful NHSx Artificial Intelligence Health and Care Award application.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.